Trading Options with an Edge
Select Page

NBIX

Search by
TICKER SYMBOL

Neurocrine Biosciences, Inc.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing

95.57

0.3

(0.315%)

Volume:

181,202

52 week range:

84.77 - 120.27

Market Cap:

9.036B

Company Description:

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.